Patents by Inventor Alexei Bogdanov

Alexei Bogdanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9095625
    Abstract: There is provided a method of preparing nanoparticles and novel nanoparticles. The nanoparticle preparation comprises the generation of a mixture comprising a plurality of metal-containing compounds and a copolymer of a polyethylene glycol and an amine-containing polyamino acid such as polylysine where a metal core and polymer shell nanoparticle is formed. The novel nanoparticles have a metallic core and a graft copolymer shell of polyethylene glycol and an amine-containing polyamino acid where the shell least partially surrounds the metallic core and is non-ionically bound to the metallic core via metal-amine bonds.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: August 4, 2015
    Assignee: University of Massachusetts
    Inventor: Alexei A. Bogdanov
  • Publication number: 20140065425
    Abstract: There is provided a method of preparing nanoparticles and novel nanoparticles. The nanoparticle preparation comprises the generation of a mixture comprising a plurality of metal-containing compounds and a copolymer of a polyethylene glycol and an amine-containing polyamino acid such as polylysine where a metal core and polymer shell nanoparticle is formed. The novel nanoparticles have a metallic core and a graft copolymer shell of polyethylene glycol and an amine-containing polyamino acid where the shell least partially surrounds the metallic core and is non-ionically bound to the metallic core via metal-amine bonds.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 6, 2014
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventor: Alexei A. Bogdanov
  • Patent number: 8563527
    Abstract: The present invention relates, in part, to an oligonucleotide-core carrier comprising a carrier, and oligonucleotide groups covalently linked to the carrier. The oligonucleotide groups are capable of dissociably linking load molecules such as therapeutic agents. The oligonucleotide-core carrier may also comprise protective side chains, and targeting molecules.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: October 22, 2013
    Assignee: Pharmain Corporation
    Inventors: Gerardo M. Castillo, Elijah M. Bolotin, Alexei A. Bogdanov, Jr.
  • Patent number: 8486373
    Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: July 16, 2013
    Assignee: The General Hospital Corporation
    Inventors: Ralph Weissleder, Ching-Hsuan Tung, Umar Mahmood, Lee Josephson, Alexei Bogdanov
  • Patent number: 8153784
    Abstract: This invention relates to biochemistry and magnetic resonance imaging.
    Type: Grant
    Filed: July 7, 2005
    Date of Patent: April 10, 2012
    Assignee: The General Hospital Corporation
    Inventors: Alexei Bogdanov, John W. Chen, Ralph Weissleder, Manel Querol
  • Patent number: 8084589
    Abstract: Described are phosphoramidite nucleoside analog monomers, precursors thereof, and oligonucleotides including one or more of the monomers. The monomers can be used during automated synthesis of oligonucleotide derivatives, and allow for incorporation of one or several reporter groups, organic molecules, bio-molecules, small molecules or other chemical groups at the internucleoside phosphotriesters. Oligonucleotides including the monomers have a number of uses in therapeutic, diagnostic, and research applications.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: December 27, 2011
    Assignees: University of Massachusetts, The General Hospital Corporation Massachusetts
    Inventors: Alexei Bogdanov, Valeriy Metelev, David Tabatadze, Paul Zamecnik
  • Publication number: 20090136940
    Abstract: Described are phosphoramidite nucleoside analog monomers, precursors thereof, and oligonucleotides including one or more of the monomers. The monomers can be used during automated synthesis of oligonucleotide derivatives, and allow for incorporation of one or several reporter groups, organic molecules, bio-molecules, small molecules or other chemical groups at the internucleoside phosphotriesters. Oligonucleotides including the monomers have a number of uses in therapeutic, diagnostic, and research applications.
    Type: Application
    Filed: August 29, 2008
    Publication date: May 28, 2009
    Applicants: University of Massachusetts, Massachusetts General Hospital
    Inventors: Alexei Bogdanov, Valeriy Metelev, David Tabatadze, Paul Zamecnik
  • Publication number: 20090053169
    Abstract: The present invention relates, in part, to an oligonucleotide-core carrier comprising a carrier, and oligonucleotide groups covalently linked to the carrier. The oligonucleotide groups are capable of dissociably linking load molecules such as therapeutic agents. The oligonucleotide-core carrier may also comprise protective side chains, and targeting molecules.
    Type: Application
    Filed: August 19, 2008
    Publication date: February 26, 2009
    Applicant: PharmaIN Corporation
    Inventors: Gerardo M. Castillo, Elijah M. Bolotin, Alexei A. Bogdanov, JR., Sandra Reichstetter
  • Publication number: 20080044827
    Abstract: This invention relates to biochemistry and magnetic resonance imaging.
    Type: Application
    Filed: July 7, 2005
    Publication date: February 21, 2008
    Inventors: Alexei Bogdanov, John Chen, Ralph Weissleder, Manel Querol
  • Patent number: 7153905
    Abstract: Hyperbranched dendron (HD) polymers are synthesized using low molecular weight polyethyleneimine (BPEI-L) as a core and used for gene delivery. The obtained polymers display low toxicity and efficient gene delivery at low nitrogen-to-phosphate (N/P) ratios. Using successive attachment of ethyleneimine moieties to a PEI core, the polymer has a lower relative ratio of linear-to-branched structures than in the core PEI. The more extensive branching enables the polymer to condense plasmid DNA into nanostructure complexes with a size of less than or equal to about 100 nm. The complexes are stable and efficient in transfecting cells in the presence of serum. Bioluminescent imaging of in vivo gene expression using a luciferase reporter gene performed in live mice showed gene expression in the liver and in submandibular lymph nodes.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: December 26, 2006
    Assignee: The General Hospital Corporation
    Inventors: Pallab Banerjee, Wilfried Reichardt, Ralph Weissleder, Alexei Bogdanov
  • Publication number: 20060275775
    Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
    Type: Application
    Filed: November 1, 2004
    Publication date: December 7, 2006
    Inventors: Ralph Weissleder, Ching-Hsuan Tung, Umar Mahmood, Lee Josephson, Alexei Bogdanov
  • Publication number: 20060258804
    Abstract: Hyperbranched dendron (HD) polymers are synthesized using low molecular weight polyethyleneimine (BPEI-L) as a core and used for gene delivery. The obtained polymers display low toxicity and efficient gene delivery at low nitrogen-to-phosphate (N/P) ratios. Using successive attachment of ethyleneimine moieties to a PEI core, the polymer has a lower relative ratio of linear-to-branched structures than in the core PEI. The more extensive branching enables the polymer to condense plasmid DNA into nanostructure complexes with a size of less than or equal to about 100 nm. The complexes are stable and efficient in transfecting cells in the presence of serum. Bioluminescent imaging of in vivo gene expression using a luciferase reporter gene performed in live mice showed gene expression in the liver and in submandibular lymph nodes.
    Type: Application
    Filed: May 11, 2006
    Publication date: November 16, 2006
    Applicant: THE GENERAL HOSPITAL CORPORATION d/b/a MASSACHUSETTS GENERAL HOSPITAL
    Inventors: Pallab Banerjee, Wilfried Reichardt, Ralph Weissleder, Alexei Bogdanov
  • Publication number: 20050079149
    Abstract: Hyperbranched dendron (HD) polymers are synthesized using low molecular weight polyethyleneimine (BPEI-L) as a core and used for gene delivery. The obtained polymers display low toxicity and efficient gene delivery at low nitrogen-to-phosphate (N/P) ratios. Using successive attachment of ethyleneimine moieties to a PEI core, the polymer has a lower relative ratio of linear-to-branched structures than in the core PEI. The more extensive branching enables the polymer to condense plasmid DNA into nanostructure complexes with a size of less than or equal to about 100 nm. The complexes are stable and efficient in transfecting cells in the presence of serum. Bioluminescent imaging of in vivo gene expression using a luciferase reporter gene performed in live mice showed gene expression in the liver and in submandibular lymph nodes.
    Type: Application
    Filed: March 22, 2004
    Publication date: April 14, 2005
    Inventors: Pallab Banerjee, Wilfried Reichardt, Ralph Weissleder, Alexei Bogdanov
  • Publication number: 20040241096
    Abstract: The invention features methods of detecting enzymatic activity (e.g., in a magnetic resonance image). In general, the methods include: (1) providing a monomeric substrate (e.g., a substrate that is polymerizable in the presence of an enzyme or as a result of an enzyme-catalyzed reaction), having the generic structure X-Y-Z, where X includes a chelator moiety having a chelated paramagnetic or superparamagnetic metal atom or ion, Y includes a linker moiety (e.g., to provide a covalent or non-covalent chemical bond or bonds between X and Z), and Z includes a polymerizing moiety; (2) contacting the substrate with a target tissue, wherein the substrate undergoes polymerization to form a paramagnetic or superparamagnetic polymer, the polymerization being catalyzed by an enzyme in an extracellular matrix or bound to the surfaces of cells of the target tissue; and (3) detecting an increase in relaxivity for the polymer relative to an equivalent amount of unpolymerized substrate.
    Type: Application
    Filed: April 30, 2004
    Publication date: December 2, 2004
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Alexei Bogdanov, Ralph Weissleder
  • Patent number: 6737247
    Abstract: The invention features methods of detecting enzymatic activity (e.g., in a magnetic resonance image). In general, the methods include: (1) providing a monomeric substrate (e.g., a substrate that is polymerizable in the presence of an enzyme or as a result of an enzyme-catalyzed reaction), having the generic structure X-Y-Z, where X includes a chelator moiety having a chelated paramagnetic or superparamagnetic metal atom or ion, Y includes a linker moiety (e.g., to provide a covalent or non-covalent chemical bond or bonds between X and Z), and Z includes a polymerizing moiety; (2) contacting the substrate with a target tissue, wherein the substrate undergoes polymerization to form a paramagnetic or superparamagnetic polymer, the polymerization being catalyzed by an enzyme in an extracellular matrix or bound to the surfaces of cells of the target tissue; and (3) detecting an increase in relaxivity for the polymer relative to an equivalent amount of unpolymerized substrate.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: May 18, 2004
    Assignee: The General Hospital Corporation
    Inventors: Alexei Bogdanov, Ralph Weissleder
  • Publication number: 20040022731
    Abstract: The invention relates to conjugates and methods for in vivo imaging of apoptosis using conjugates of fluorochromes and moieties that bind specifically to apoptotic cells. In specific embodiments, the fluorochrome emits fluorescence in the near-infrared range and is conjugated to a moiety, e.g., a protein such as annexin A5 or synaptotagmin, that binds specifically to apoptotic cells. The methods are non-invasive can be used to obtain images of apoptotic cells in the tissues of living animals, e.g., mammals such as humans.
    Type: Application
    Filed: April 25, 2003
    Publication date: February 5, 2004
    Inventors: Alexei Bogdanov, Eyk Schellenberger, Alexander Petrovsky, Lee Josephson
  • Publication number: 20030219383
    Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
    Type: Application
    Filed: February 7, 2003
    Publication date: November 27, 2003
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Ralph Weissleder, Ching-Hsuan Tung, Umar Mahmood, Lee Josephson, Alexei Bogdanov
  • Patent number: 6592847
    Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluorescence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: July 15, 2003
    Assignee: The General Hospital Corporation
    Inventors: Ralph Weissleder, Ching-Hsuan Tung, Umar Mahmood, Lee Josephson, Alexei Bogdanov
  • Publication number: 20020142297
    Abstract: Described are short peptide sequences, termed recombinant peptide chelates (RPCs), and the imaging marker genes that encode them. The RPCs can be expressed in parallel with the expression of any other desired gene (e.g., a therapeutic gene), and used to easily confirm the expression of the therapeutic gene product. The RPCs are expressed in the cell or on the cell surface concurrently with the therapeutic gene product, and can be assayed by standard imaging techniques.
    Type: Application
    Filed: December 18, 2000
    Publication date: October 3, 2002
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Alexei A. Bogdanov, Ralph Weissleder, Maria Simonova
  • Publication number: 20020127629
    Abstract: The invention features methods of detecting enzymatic activity (e.g., in a magnetic resonance image). In general, the methods include: (1) providing a monomeric substrate (e.g., a substrate that is polymerizable in the presence of an enzyme or as a result of an enzyme-catalyzed reaction), having the generic structure X-Y-Z, where X includes a chelator moiety having a chelated paramagnetic or superparamagnetic metal atom or ion, Y includes a linker moiety (e.g., to provide a covalent or non-covalent chemical bond or bonds between X and Z), and Z includes a polymerizing moiety; (2) contacting the substrate with a target tissue, wherein the substrate undergoes polymerization to form a paramagnetic or superparamagnetic polymer, the polymerization being catalyzed by an enzyme in an extracellular matrix or bound to the surfaces of cells of the target tissue; and (3) detecting an increase in relaxivity for the polymer relative to an equivalent amount of unpolymerized substrate.
    Type: Application
    Filed: October 19, 2001
    Publication date: September 12, 2002
    Inventors: Alexei Bogdanov, Ralph Weissleder